Feng Lin
Impact in
- Hematology top 0.5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 19
- Chronic Myeloid Leukemia Treatments 15
- Acute Myeloid Leukemia Research 5
- Genetics 15
- Chronic Lymphocytic Leukemia Research 13
- Co-authors
- Nicholas C.P. CrossFrits van RheeAndrew ChaseJM GoldmanJ BungeyTerry P. HughesJ V MeloJ M Goldman
- Journals
- Blood (4 papers)British Journal of Haematology (3 papers)Leukemia (3 papers)Journal of Clinical Oncology (2 papers)Oncogene (2 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Feng Lin
54 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 101
- Hematology 1.5k
- Genetics 807
- Rheumatology 352
- Cancer Research 282
- Public Health, Environmental and Occupational Health 452
Countries citing papers authored by Feng Lin
This map shows the geographic impact of Feng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Lin more than expected).
Fields of papers citing papers by Feng Lin
This network shows the impact of papers produced by Feng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Lin. The network helps show where Feng Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 10 | |
| 4 | 2022 | 5 | |
| 5 | 2021 | 10 | |
| 6 | 2021 | 6 | |
| 7 | 2021 | 12 | |
| 8 | 2021 | 2 | |
| 9 | 2017 | 4 | |
| 10 | 2010 | 27 | |
| 11 | Relationship between adiponectin level and insulin resistance in offsprings of patients with gestational diabetes mellitus | 2010 | 1 |
| 12 | 2010 | 24 | |
| 13 | Relationship between the adiponectin and TNF-α with insulin resistance in patients with gestational diabetes mellitus. | 2009 | 1 |
| 14 | 2007 | 33 | |
| 15 | 2006 | 87 | |
| 16 | 2006 | 24 | |
| 17 | Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. | 2001 | 470 |
| 18 | 2001 | 25 | |
| 19 | 1999 | 32 | |
| 20 | An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders. | 1994 | 204 |
About Feng Lin
Feng Lin is a scholar working on Hematology, Genetics, Behavioral Neuroscience, Cancer Research and Complementary and alternative medicine, having authored 56 papers that have together received 2.3k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (15 papers), Chronic Lymphocytic Leukemia Research (13 papers), Cancer-related molecular mechanisms research (7 papers), Eosinophilic Disorders and Syndromes (6 papers), Acute Myeloid Leukemia Research (5 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers), Cancer-related gene regulation (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). The work is most often cited by research in Hematology (1.5k citations), Genetics (807 citations), Rheumatology (352 citations), Cancer Research (282 citations) and Public Health, Environmental and Occupational Health (452 citations). Feng Lin has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Nicholas C.P. Cross, Frits van Rhee, Andrew Chase, JM Goldman, J Bungey, JM Goldman, Terry P. Hughes, J V Melo, J M Goldman and Susan P. Whitman. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, Journal of Clinical Oncology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.